However, although the autophagy inhibitors and PD-L1-resistant agents used in combination provide opportunities for enhanced antitumor activity, autophagy inhibition affects immune system-mediated tumor cell death as part of a complex channel network, and further experiments are needed to guide this synergy, especially in the initial stage of tumor progression. The gene discussed is CD274; the disease is neoplasm.